
Zhi Hong - Brii Biosciences | LinkedIn
View Zhi Hong’s profile on LinkedIn, a professional community of 1 billion members. I led global R&D unit in infectious diseases for more than 10 years at a major…
- 500+ connections
- Location: Brii Biosciences
Zhi Hong, PhD - Society for Translational Oncology
Zhi Hong, PhD, is Executive Director, Chairman of the Board and CEO of Brii Biosciences which he founded in 2018. Prior to starting Brii Biosciences, Zhi was Senior Vice President and Head of GlaxoSmithKline’s (GSK) Infectious Diseases Therapy Area Unit.
Leadership | Brii Biosciences
Zhi Hong, Ph.D. Executive Director, Chairman of the Board and Chief Executive Officer Dr. Hong co-founded Brii Bio in 2018 and has served as Chief Executive Officer since the company’s inception.
Zhi Hong - Co-Founder and Chief Executive Officer - Crunchbase
Zhi Hong, Ph.D., is Co-founder and Chief Executive Officer. Prior to starting Brii Bio, Dr. Hong was Senior Vice President and Head of GlaxoSmithKline's (GSK) Infectious Diseases Therapy Area Unit. He was widely credited as the key architect of GSK's comeback and success in HIV & Infectious Diseases medicine discovery and development.
GlaxoSmithKline veteran Zhi Hong launches Brii Biosciences with …
May 24, 2018 · Zhi Hong, an 11-year veteran of GlaxoSmithKline, is striking out on his own with a startup geared to improve public health in China.
Zhi Hong | University of Chicago | 14 Publications | 49 Citations ...
Zhi Hong is an academic researcher from University of Chicago. The author has contributed to research in topics: Computer science & Named-entity recognition. The author has an hindex of 5, co-authored 9 publications. Previous affiliations of Zhi Hong include Argonne National Laboratory.
Zhi Hong - Executive Director, Chairman of the Board & CEO at …
Dr. Hong co-founded Brii Bio in 2018 and has served as Chief Executive Officer since the company’s inception. Prior to starting Brii Bio, Dr. Hong was Senior Vice President and Head of GlaxoSmithKline's (GSK) Infectious Diseases Therapy Area Unit.
Zhi-Hong Mao - University of Pittsburgh
(2016) Chancellor’s Distinguished Teaching Award, University of Pittsburgh. (2015 - 2019) William Kepler Whiteford Faculty Fellowship (renewed), Swanson School of Engineering, University of Pittsburgh. (2013) Outstanding Service Award as Associate Editor, IEEE Transactions on Intelligent Transportation Systems.
PtdIns3P controls mTORC1 signaling through lysosomal positioning
Dec 4, 2017 · Here we present results that connect these seemingly unrelated pathways for mTORC1 activation. Amino acids stimulate recruitment of the PtdIns3P-binding protein FYCO1 to lysosomes and promote contacts between FYCO1 lysosomes and endoplasmic reticulum that contain the PtdIns3P effector Protrudin.
Zhi Hong Mao | Pitt Space
Zhi-Hong Mao is a Professor in the Department of Electrical and Computer Engineering and Department of Bioengineering at the University of Pittsburgh, Pittsburgh, PA. His space-related research interests include astrodynamics, spacecraft control systems, AI and machine learning, and human-machine systems.
- Some results have been removed